Anacor to Detail Chemistry Behind Lead Compounds

Date Posted: Monday, September 18, 2006

Print Email to a friend

Anacor Pharmaceuticals has announced it has made two presentations at the American Chemical Society National Meeting & Exposition this week in San Francisco.

Researchers have made an oral presentation on the chemistry and discovery of AN2690, Anacor's topical antifungal drug candidate being developed for onychomycosis, a fungal infection of the toenail and nail bed, as well as a poster presentation on the discovery of AN0128, Anacor's treatment for atopic dermatitis.

The conference is being held at the Moscone Center.

AN0128 Poster Presentation:

MEDI 332
Discovery and SAR of diphenylborinic acid picolinate esters as a potent antibacterial and anti-inflammatory agent for the treatment of skin diseases

General Poster Session : 7 to 9 p.m., Wednesday, Sept. 13, Moscone Center - Hall D

AN2690 Oral Presentation:

MEDI 296
Discovery and SAR of a boron-containing clinical molecule (AN-2690) for topical onychomycosis treatment

General Oral Session : 1:30 to 4:50 p.m., Tuesday, Sept. 12, Moscone Center - Room 103

Further Information: http://www.anacor.com/

  


HTOS